When these mutations were corrected back to the WT allele, dropout of DLBCL cells was observed compared to isogenic cells retaining the BCL6 SE mutation [48]. These data show how the process of somatic hypermutation in B cells amplify SE-mediated oncogene expression. The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.